ストックスクリーナーアプリを入手
9.41
3.38%
0.24
前日終値:
$9.17
開ける：
$9.16
24時間の取引高:
199.53K
Relative Volume:
0.16
時価総額：
$571.06M
収益：
$217.11M
当期純損益:
$-651.19M
株価収益率:
-0.7244
EPS:
-12.99
ネットキャッシュフロー:
$-387.26M
1週間 パフォーマンス:
+14.08%
1か月 パフォーマンス:
+2.49%
6か月 パフォーマンス:
-16.48%
1年 パフォーマンス:
-15.36%
1日の値動き範囲:
$9.08
$9.4899
1週間の範囲:
$8.33
$9.46
52週間の値動き範囲:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
名前
Ginkgo Bioworks Holdings Inc
セクター
電話
(877) 442-5362
住所
27 DRYDOCK AVENUE, BOSTON
DNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
9.425 | 555.61M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.94 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
800.00 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.04 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
813.49 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.28 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-15 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-05-10 | ダウングレード | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-02 | ダウングレード | Goldman | Neutral → Sell |
| 2023-05-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 開始されました | Berenberg | Buy |
| 2022-10-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2022-02-23 | 開始されました | Goldman | Neutral |
| 2022-02-01 | 開始されました | BofA Securities | Neutral |
| 2022-01-28 | 開始されました | BofA Securities | Buy |
| 2022-01-07 | 開始されました | BTIG Research | Buy |
| 2021-11-29 | 開始されました | Jefferies | Buy |
| 2021-10-13 | 開始されました | Raymond James | Outperform |
| 2021-10-12 | 開始されました | William Blair | Outperform |
| 2021-09-20 | 開始されました | HSBC Securities | Buy |
すべてを表示
Ginkgo Bioworks Holdings Inc (DNA) 最新ニュース
Why hedge funds are buying Ginkgo Bioworks Holdings Inc. stock2026 world cup usa national team qualification star players transition play odds analysis preview - Улправда
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks announces COO transition and operational leadership changes By Investing.com - Investing.com Australia
Ginkgo Bioworks announces COO transition and operational leadership changes - Investing.com
Is Ginkgo Bioworks Holdings Inc a good long term investmentInsider Trading Compliance & Affordable Trading Techniques - earlytimes.in
Penny Stocks That Will Make You Richcareer Html Definition Characteristics & How To Invest - shababeek.org
Ginkgo Bioworks Holdings, Inc. (DNA) rises as market takes a dip: Key facts - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0% - simplywall.st
Liquidity Mapping Around (DNA) Price Events - Stock Traders Daily
Ginkgo Bioworks announces operating leadership transition effective January 2026 - Investing.com India
Ginkgo Bioworks realigns leadership, shifts COO responsibilities - MSN
Ginkgo Bioworks announces operating leadership transition effective January 2026 By Investing.com - Investing.com Australia
Ginkgo Bioworks Announces COO Transition - TradingView — Track All Markets
Ginkgo Bioworks shifts operating duties in leadership restructure - StreetInsider
Ginkgo Bioworks (NYSE: DNA) realigns leadership as Shetty refocuses on lab - Stock Titan
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach - Sahm
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans - Sahm
Ginkgo Bioworks, Carnegie Mellon Partner on At-Home Cancer Detection Technology - marketscreener.com
Ginkgo Bioworks partners with CMU on innovative cancer detection By Investing.com - Investing.com Canada
Ginkgo Bioworks (NYSE:DNA) Trading Up 10%Time to Buy? - MarketBeat
How rising interest rates impact Ginkgo Bioworks Holdings Inc. stock2025 Historical Comparison & Weekly Chart Analysis and Guides - bolumsonucanavari.com
Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketJuly 2025 Price Swings & Low Drawdown Trading Strategies - Улправда
Is Ginkgo Bioworks Holdings Inc. stock resilient to inflationEarnings Miss & Consistent Income Trade Ideas - DonanımHaber
Is Ginkgo Bioworks Holdings Inc. stock a contrarian buy2025 Price Momentum & Weekly Top Performers Watchlists - Улправда
Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessJuly 2025 Rallies & Daily Profit Focused Stock Screening - DonanımHaber
Will Ginkgo Bioworks Holdings Inc. stock maintain momentum in 20252025 Volatility Report & Safe Capital Allocation Plans - Улправда
Ginkgo Bioworks, Agricen Collaborate on Soil Amendment Fermentation - marketscreener.com
Ginkgo Bioworks and Agricen complete fermentation process optimization By Investing.com - Investing.com Canada
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment - Finviz
New partnership speeds up production of helpful soil bacteria for crops - Stock Titan
CFO Coen Acquires 750 Of Ginkgo Bioworks Holdings Inc [DNA] - TradingView — Track All Markets
Ginkgo Bioworks Holdings, Inc. (DNA) insider details RSU vesting and tax sale - Stock Titan
DNA (NYSE: DNA) holder plans sale of 736 Class A shares on NYSE per notice - Stock Titan
Price-Driven Insight from (DNA) for Rule-Based Strategy - Stock Traders Daily
What analysts say about Ginkgo Bioworks Holdings Inc stockDividend Stability Analysis & Rapid Portfolio Gain - earlytimes.in
Ginkgo Bioworks awarded four-year, up to $47M contract from EMSL - MSN
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies - Investing News Network
Jump Financial LLC Acquires New Stake in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Treas Che Files To Sell 2,200 Of Ginkgo Bioworks Holdings Inc [DNA] - TradingView — Track All Markets
Ginkgo Bioworks (NYSE: DNA) insider files to sell 2,200 shares - Stock Titan
Recent Uptick Might Appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Institutional Owners After Losing 13% Over the Past Year - 富途牛牛
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety - Investing News Network
Ginkgo Bioworks Partners With Deep Origin-Led Team on ARPA-H to Develop Drug Safety Platform - marketscreener.com
Ginkgo Bioworks Partners on Deep Origin-Led Team to Develop New Tools for Pred Predictive Drug Safety - marketscreener.com
Ginkgo Bioworks partners with Deep Origin on ARPA-H drug safety project - Investing.com UK
Ginkgo Bioworks (NYSE:DNA) Shares Gap UpWhat's Next? - MarketBeat
Ginkgo Bioworks to Hold Special Meeting of Shareholders - GuruFocus
Ginkgo Bioworks secures $47M contract from PNNL for phenotyping platform - Investing.com
Ginkgo Bioworks secures $47M contract from PNNL for phenotyping platform By Investing.com - Investing.com South Africa
Ginkgo Bioworks Awarded 4-Year Energy Department Contract Valued at Up to $47 Million - marketscreener.com
Ginkgo Bioworks Holdings Inc (DNA) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):